Literature DB >> 16002712

Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses.

Vanja Lazarevic1, Dawn Nolt, JoAnne L Flynn.   

Abstract

The primary goal of this study was to determine how chronic exposure to Ag influences the functionality of Mycobacterium tuberculosis-specific T cell responses. The frequency of IFN-gamma-producing effector CD4(+) and CD8(+) T cells dynamically changed during persistent M. tuberculosis infection. CD8(+) T cells used differential effector functions during acute and chronic phases of the immune response, where CD8(+) T cells produced negligible amounts of IFN-gamma early in infection, but switched to cytokine production during the chronic stage of infection. Using limiting dilution analysis, CD8(+) T cells isolated during the initial phase of infection demonstrated lytic potential, but this waned in the chronic stage. The apparent loss of cytotoxic activity was not associated with the lack of perforin. Ag dose could potentially govern the functional program of CD8(+) T cells. Collectively, these results depict a host immune response mounted against M. tuberculosis of a significantly more dynamic nature than previously recognized.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002712     DOI: 10.4049/jimmunol.175.2.1107

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  CD4 T cell depletion exacerbates acute Mycobacterium tuberculosis while reactivation of latent infection is dependent on severity of tissue depletion in cynomolgus macaques.

Authors:  Philana Ling Lin; Tara Rutledge; Angela M Green; Matthew Bigbee; Carl Fuhrman; Edwin Klein; JoAnne L Flynn
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-04       Impact factor: 2.205

Review 2.  New insights into mathematical modeling of the immune system.

Authors:  Penelope A Morel; Shlomo Ta'asan; Benoit F Morel; Denise E Kirschner; Joanne L Flynn
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish.

Authors:  Hilary Clay; J Muse Davis; Dana Beery; Anna Huttenlocher; Susan E Lyons; Lalita Ramakrishnan
Journal:  Cell Host Microbe       Date:  2007-07-12       Impact factor: 21.023

Review 4.  Insights into early mycobacterial pathogenesis from the zebrafish.

Authors:  Robin Lesley; Lalita Ramakrishnan
Journal:  Curr Opin Microbiol       Date:  2008-06-19       Impact factor: 7.934

5.  Gammadelta T cells and Th17 cytokines in hypersensitivity pneumonitis and lung fibrosis.

Authors:  Philip L Simonian; Christina L Roark; Willi K Born; Rebecca L O'Brien; Andrew P Fontenot
Journal:  Transl Res       Date:  2009-09-09       Impact factor: 7.012

6.  A review of computational and mathematical modeling contributions to our understanding of Mycobacterium tuberculosis within-host infection and treatment.

Authors:  Denise Kirschner; Elsje Pienaar; Simeone Marino; Jennifer J Linderman
Journal:  Curr Opin Syst Biol       Date:  2017-05-22

7.  Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis.

Authors:  Claudia Sala; Neeraj Dhar; Ruben C Hartkoorn; Ming Zhang; Young Hwan Ha; Patricia Schneider; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2010-08-02       Impact factor: 5.191

8.  Early control of Mycobacterium tuberculosis infection requires il12rb1 expression by rag1-dependent lineages.

Authors:  Halli E Miller; Richard T Robinson
Journal:  Infect Immun       Date:  2012-08-20       Impact factor: 3.441

9.  A replication clock for Mycobacterium tuberculosis.

Authors:  Wendy P Gill; Nada S Harik; Molly R Whiddon; Reiling P Liao; John E Mittler; David R Sherman
Journal:  Nat Med       Date:  2009-02-01       Impact factor: 53.440

10.  Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles.

Authors:  Andreia P Soares; Thomas J Scriba; Sarah Joseph; Ryhor Harbacheuski; Rose Ann Murray; Sebastian J Gelderbloem; Anthony Hawkridge; Gregory D Hussey; Holden Maecker; Gilla Kaplan; Willem A Hanekom
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.